KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardant Health (GH) EBIAT (2017 - 2026)

Guardant Health's EBIAT history spans 9 years, with the latest figure at -$128.5 million for Q4 2025.

  • On a quarterly basis, EBIAT fell 15.75% to -$128.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$416.3 million, a 4.61% increase, with the full-year FY2025 number at -$416.3 million, up 4.61% from a year prior.
  • EBIAT hit -$128.5 million in Q4 2025 for Guardant Health, down from -$92.7 million in the prior quarter.
  • Over the last five years, EBIAT for GH hit a ceiling of -$72.3 million in Q4 2021 and a floor of -$229.4 million in Q2 2022.
  • Historically, EBIAT has averaged -$118.6 million across 5 years, with a median of -$107.6 million in 2021.
  • Biggest five-year swings in EBIAT: crashed 237.3% in 2021 and later skyrocketed 68.28% in 2023.
  • Tracing GH's EBIAT over 5 years: stood at -$72.3 million in 2021, then tumbled by 93.52% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then soared by 40.65% to -$111.0 million in 2024, then decreased by 15.75% to -$128.5 million in 2025.
  • Business Quant data shows EBIAT for GH at -$128.5 million in Q4 2025, -$92.7 million in Q3 2025, and -$99.9 million in Q2 2025.